You have access
Sorafenib plus Daily Low-dose Temozolomide for Relapsed Glioblastoma: A Phase II Study
FABLE ZUSTOVICH, LORENZA LANDI, GIUSEPPE LOMBARDI, CAMILLO PORTA, LUCA GALLI, ANDREA FONTANA, DOMENICO AMOROSO, COSTANZA GALLI, MICHELE ANDREUCCETTI, ALFREDO FALCONE and VITTORINA ZAGONEL
Anticancer Research August 2013, 33 (8) 3487-3494;